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Ethnopharmacological relevance: Indigo naturalis has been used to treat inﬂammatory diseases and
dermatosis, including psoriasis, since thousands of years in China. It has been proven effective in our
previous clinical studies on treating psoriasis, but the active component and the mechanism of how
indigo naturalis working still needs to be clariﬁed. Since the dysregulated angiogenesis is known to play
an important role in the pathogenesis of psoriasis, the anti-angiogenic effect of indigo naturalis and
tryptanthrin, a pure component of indigo naturalis, was investigated.
Materials and methods: The in vivo angiogenesis was studied by chick chorioallantoic membrane assay. The
in vitro studies were performed using human vascular endothelial cells. Cell viability was determined by MTT
assay. Cell cycle distribution was revealed by ﬂow cytometry. The cellular messenger (m)RNA or protein
expression level was analyzed by real-time RT-PCR or Western blot, respectively. Transwell ﬁlter migration
assay and matrix gel-induced tube formation method were applied to examine the angiogenic potential.
Results: Indigo naturalis signiﬁcantly inhibited the in vivo vascular endothelial growth factor (VEGF)-induced
angiogenesis, as well as tryptanthrin. In vitro studies conﬁrmed that indigo naturalis and tryptanthrin re-
duced the number of viable vascular endothelial cells. Tryptanthrin resulted in a cell cycle arrest and dose-
dependently decreased the expressions of cyclin A, cyclin B, cyclin dependent kinase(CDK) 1 and 2, but not
cyclin D and cyclin E, at both the mRNA and protein levels. The migration and tube formation of vascular
endothelial cells were signiﬁcantly inhibited by tryptanthrin in a dose-dependent manner. Result also
showed that tryptanthrin could reduce the phosphorylated levels of both protein kinase B (PKB or Akt) and
focal adhesion kinase (FAK).
Conclusions: All together, these results demonstrated the anti-angiogenic effect of tryptanthrin, the acting
component of indigo naturalis and revealed the underlying mechanism by inhibiting the cell cycle pro-
gression, cell migration and tube formation, likely mediated through blocking the Akt and FAK pathways.
& 2015 The Authors. Published by Elsevier Ireland Ltd. This is an open access article under the CC BY-NC-ND
license (http://creativecommons.org/licenses/by-nc-nd/4.0/).1. Introduction
Angiogenesis is characterized by forming new vascular net-
work from pre-existing vessels, and plays an important role in
several diseases, such as malignancy and psoriasis (Miao et al.,r Ireland Ltd. This is an open acces
Medical Sciences, College of
Road, Kwei-Shan, Tao-Yuan,
ang).
buted to this work equally.2011; Yu et al., 2009). This physiological process is mediated by
several factors including VEGF, platelet derived growth factor
(PDGF), matrix metalloproteinase (MMP), and angiopoietins (Ang),
all of which facilitate proliferation, migration, and tube formation
of vascular endothelial cells (Carmeliet and Jain, 2011; Wang et al.,
2013). Agents targeting the process of angiogenesis are getting
considerable attentions by researchers over the past few decades,
and currently still remains as an important issue.
Psoriasis is a chronic immune-mediated inﬂammatory skin
disease mostly characterized by erythematous, scaly, well-s article under the CC BY-NC-ND license
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of the key events involving the pathogenesis of psoriasis (Chung
et al., 2010). The evidence includes that new blood vessels for-
mation develops from the beginning of psoriasis and disappears
after disease clearance as well as several angiogenic mediators and
proangiogenic cytokines are up-regulated during development of
psoriasis (Gould and Wong, 2002).
Indigo naturalis (QingDai), a dark blue powder extracted from
the leaves of indigo-bearing plants, has been used for thousands of
years in China for various inﬂammatory diseases and dermatosis,
including psoriasis. Previous clinical trials proved that Composite
Indigo Naturalis tablets containing arsenic sulﬁde had high com-
plete remission rate in patients with acute promyelocytic leukemia
(Wang, 2001). Orally use of indigo naturalis in treating psoriasis
has been proved effective in previous clinical reports (Yuan et al.,
1982), however, adverse gastrointestinal effects and liver damage
has been reported (Verucchi et al., 2002). Our previous clinical
studies have shown that topical use of ointment-based indigo
naturalis improved the epidermal thickness, leukocyte inﬁltration,
and angiogenesis of the psoriatic skin lesion safely and effectively
(Lin et al., 2007). Indigo naturalis has been proved to modulate
differentiation and proliferation of keratinocytes, downregulate
inﬂammatory reactions by suppressing human neutrophils and
vascular cell adhesion molecule-1 expression in human umbilical
vein endothelial cells (HUVECs), inhibit epidermal growth factor
(EGFR) activation and EGF-induced CDC25B gene expression, and
upregulate claudin-1 expression in human keratinocytes (Chang
et al., 2010; Hsieh et al., 2012; Lin et al., 2013; Lin et al., 2009a; Lin
et al., 2009b). However, the mechanism of how indigo naturalis
regulates angiogenesis remains unclear.
Tryptanthrin, one of the major active ingredients of indigo
naturalis, is ﬁrst isolated from Strobilanthes cusia O. Kuntze. as an
anti-fungal agent against dermatophytes (Honda and Tabata,
1979). The anti-inﬂammatory and immunomodulatory activities of
tryptanthrin have also been reported (Ishihara et al., 2000; Recio
et al., 2006). In recent years, studies on anti-tumor effect of
tryptanthrin are getting more and more popular, such as inducing
apoptosis and differentiation of leukemia cells (Kimoto et al.,
2001; Miao et al., 2011), inhibiting drug resistance-related genes in
breast and colon cancer cells (Yu et al., 2009; Zhu et al., 2011), andFig. 1. (A) The chromatographic ﬁngerprint of indigo naturalis revealed three major co
reference standards. (B) Chemical structure of tryptanthrin.inducing differentiation as well as growth inhibition in neuro-
blastoma cells and radiosensitization in non-small cell lung cancer
cells has been proven (Kim et al., 2013; Liao and Leung, 2013).
Since cancer and psoriasis share the same pathogenesis of angio-
genesis, we supposed that indigo naturalis has anti-angiogenesis
effect and the active component might be tryptanthrin.
The anti-angiogenic effect of tryptanthrin has been mentioned
previously (Liao et al., 2013), however, the anti-angiogenetic effect
and related mechanism of indigo naturalis and its component
tryptanthrin have not been fully understood, the aim of our study
was to further elucidate the related genes and pathways that were
affected by tryptanthrin by in vitro and in vivo methods.2. Materials and methods
2.1. Reagents
The indigo naturalis was prepared from the plant Strobilanthes
formosanus Moore (Acanthaceae) and provided by Dr. Yin-Ku Lin
(Keelung Chang Gung Memorial hospital, Taiwan). The ﬁngerprints
and quantity analysis of standard samples, indirubin, indigo, and
tryptanthrin, were established by Dr. Yann-Lii Leu, shown in
Fig. 1A. A voucher specimen (SF-1) was deposited in the herbarium
of Chang Gung University, Taoyuan, Taiwan. The indigo naturalis
powder was dissolved in dimethyl sulfoxide (DMSO) in a propor-
tion of 1:10 (w/v), then sterilized by ﬁltration (pore size 0.2 μm),
and stored at 20 °C for following experiments.
Tryptanthrin, 3-[4,5-dimethylthiazol-2-yl]-2,5-diphenylte-
trazolium bromide (MTT) and ECM gel prepared from Engelbreth
Holm-Swarm mouse sarcoma were purchased from Sigma. The
chemical structure is shown in Fig. 1B. VEGF was obtained from
R&D Systems (Minneapolis, MN, USA).
2.2. Cell culture
Human vascular endothelial cells were isolated by collagenase
digestion of the human umbilical cord veins obtained from Chang
Gung Memorial Hospital with the informed consents signed by
donors. Human vascular endothelial cells were cultured in M199mponents, indirubin, indigo, and tryptanthrin, as identiﬁed by comparisons with
Fig. 2. Indigo naturalis and tryptanthrin inhibited in vivo VEGF-induced angio-
genesis on the chorioallantoic membrane of chicken embryo. CAMs, with or
without 50 μg indigo naturalis or 1 μg tryptanthrin, were stimulated by 100 ng
VEGF for 48 h. The angiogenesis index were calculated and shown as mean7SEM
from three independent experiments (compared with control, *Po0.05; compared
with VEGF only/VEGF plus DMSO-treated groups, #Po0.05).
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endothelial cell growth factor supplement (ECGF, Sigma, St. Louis,
MO, USA) and 100 U/mL penicillin-100 μg/mL streptomycin (Gibco
BRL, Life Technologies, Grand Island, NY, USA) at 37 °C in a hu-
midiﬁed incubator containing 5% CO2/95% air Cells were trypsi-
nized when they reached 80–90% conﬂuence and were passagedFig. 3. Indigo naturalis and tryptanthrin suppressed the cell proliferation of vascular end
naturalis for 24 h and cell viability was determined by MTT assay. (B) Cells were treated
MTT assay. Result was calculated from three independent experiments. (C) Cell cycle a
performed by ﬂow cytometry. (D) The percentage of cells in each cell cycle phase wasinto gelatin-coated dishes. Cells were used for the experiment
from passage 3–5.
2.3. Embryonic chick chorioallantoic membrane (CAM) assay
In vivo angiogenesis was determined by CAM assay using
8-day-old chick embryos. By using a small craft drill, a small hole
was made through the shell of chick eggs at the air sac end, and
then a second hole was drilled on the broad side of the egg directly
over embryonic blood vessels. A false air sac was created by ap-
plying negative pressure to the original hole which pulled away
the CAM. A window was cut through the shell over the dropped
CAM and saturated with 100 μL of sterile 1PBS (phosphate
buffer solution) containing 100 ng VEGF in the presence or ab-
sence of indigo naturalis (500 μg/ml) or tryptanthrin (10 μM). The
shells were covered with adhesive tape and incubated in a 37 °C
incubator. The CAM tissues were harvested after 48 h and ex-
amined for angiogenesis under a stereomicroscope (Zeiss, Ger-
many). The angiogenic index was deﬁned as the mean number of
visible blood vessel branch points within the deﬁned area of the
membrane. Photographs were taken at 16 magniﬁcation.
2.4. Colorimetric MTT assay
Cells with different concentration of indigo naturalis (0, 10, 50,
250, 500 and 1000 μg/ml) or tryptanthrin (0, 10, 25 and 50 μM)
treatment for 24 h are washed once with cord buffer, followed by
adding 1 ml DMEM containing 50 μg/ml MTT for 1 h at 37 °C. After
removing the media, DMSO was added to solubilize the formazanothelial cells. (A) Cells were treated with 0, 10, 50, 250, 500 and 1000 μg/ml indigo
with 0, 10, 25 and 50 μM tryptanthrin for 24 h and cell viability was determined by
nalysis of untreated and 50 μM tryptanthrin-treated vascular endothelial cells was
summarized.
Fig. 4. Tryptanthrin regulated the expression of cell cycle genes in vascular endothelial cells. After treated with 0, 10, 25 and 50 μM tryptanthrin for 24 h, (A, B) mRNA and
(C) protein levels of cyclin D, cyclin E, cyclin A, cyclin B, CDK1, and CDK2 were determined by real-time RT-PCR and Western blot analysis, respectively. (D) Densitometric
analysis of the protein levels in (C). Result was presented as mean7SEM from three independent experiments (compared with control, *Po0.05).
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spectrophotometer. Control values for DMSO alone were sub-
tracted from all readings, and the mean optical densities were
calculated.
2.5. Transwell ﬁlter migration assay
Transwell ﬁlters (Costar, Cambridge, MA) with 8.0 mm pores
were used for the migration assay. Cells were seeded at a density
of 1.2105 cells per ﬁlter. The inner chamber was ﬁlled with
250 μl M199 medium and 1% FCS, and the outer chamber was
ﬁlled with 600 μl EC medium. Cells were treated with 0, 10, 25 and
50 μM tryptanthrin for 24 h, trypsinized and allowed to migrate
for 4 h at 37 °C in an atmosphere of 5% CO2/95% air. Cells on ﬁlters
were stained with Liu's stain and then washed twice in PBS. Cells
on the upper surface of the ﬁlter were removed using a cotton
swab. Cells on the lower surface of the ﬁlter were counted undersix random high-power microscopic ﬁelds (HPF) per ﬁlter and the
mean number of migrating cells was calculated for each condition.2.6. ECM gel-induced capillary tube formation
The extracellular matrix (ECM) gel-induced capillary tube for-
mation assay was used as an in vitro measurement of angiogen-
esis. Brieﬂy, a 24-well culture plate was coated with 80 μl/well
ECM gel and allowed to stand for 30 min at 37 °C to form a gel
layer. After gel formation, 1105 HUVECs in 0.5 ml of growth
medium were seeded to each well and treated with different
concentration of tryptanthrin (0, 10, 25 and 50 μM). The plate was
incubated at 37 °C in a humidiﬁed atmosphere with 5% CO2/95%
air for 4 h and the formation of capillary tubes were photographed
with the use of an inverted microscope.
Fig. 5. Tryptanthrin reduced the cell migration of vascular endothelial cells. Cells
were treated with 0, 10, 25 and 50 μM tryptanthrin for 24 h, trypsinized and al-
lowed to migrate using transwell ﬁlter for 4 h. (A) Cells on the lower surface of the
ﬁlter were stained and counted under contract microscope (100HPF). (B) Result
was presented as mean7SEM calculated from three independent experiments
(compared with control, *Po0.05).
Fig. 6. Tryptanthrin reduced the matrix-induced tube formation of vascular en-
dothelial cells. (A) Cells were treated with 0, 10, 25 and 50 μM tryptanthrin for 24 h,
trypsinized and processed for tube formation on matrix gel for 4 h and photo-
graphed. (B) The number of completely formed tubes in each group was calculated.
Result was presented as mean7SEM from three independent experiments (com-
pared with control, *Po0.05).
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Cells without or with 50 μM tryptanthrin treatment for 24 h
were washed twice in phosphate-buffered saline (PBS) and ﬁxed in
1 ml of 70% methanol in PBS for 1 h at 20 °C. Cells were cen-
trifuged at 3000g for 5 min, resuspended in 1 ml of 0.5% Triton
X-100, 0.05% RNase A in PBS, and incubated at 37 °C for 1 h. Cell
suspensions were centrifuged, washed, and resuspended in 1 ml of
50 mg/ml propidium iodide solution in PBS. Cells were stored
overnight at 4 °C. The cells were then analyzed by ﬂow cytometry
on a FACScan (Becton Dickinson, San Francisco, CA), and percen-
tages of cells in G1, S, and G2/M phase were calculated.
2.8. Quantitative real-time RT-PCR analysis
After treated with 0, 10, 25 and 50 μM tryptanthrin for 24 h,
total RNA was extracted from cells using TRIZOL reagent (Life
Technology, 1 mL/107 cells), and then extracted with chloroform:
isoamyl alcohol (49:1) to remove proteins and genomic DNAs.
Complementary (c) DNA was synthesized using 1 mg total RNA in
a 20 mL volume RT reaction mix containing 0.5 mg of random
primers, 0.8 mM dNTP, 0.1 M DTT and 1ﬁrst strand buffer.
Quantitative real-time RT-PCR was performed using an EvaGreen
dye (Biotium) and MxPro-M3000P qPCR machine (Stratagene).
Aliquots (20 ηg) of cDNA were used for each quantitative PCR, and
each reaction was run in triplicate. Relative gene expressions be-
tween experimental groups were determined using MxPro soft-
ware (Stratagene) and Glyceraldehyde 3-phosphate dehy-
drogenase (GADPH) was used as an internal control. The following
primers were used: CDK1: 5′-GGGTCAGCTCGTTACTCA-3′ (for-
ward) and 5′-CGTTTGGCTGGATCATAG-3′ (reverse), CDK2: 5′-
CTTTGGAGTCCCTGTCCGTA-3′ (forward) and 5′-CGAAAGATCCGG-AAGAGTTG-3′ (reverse), cyclin A: 5′-TTCCGACACTCTTCCTTC-3′
(forward) and 5′-TGGTCTCACCGATACACTT-3′ (reverse), cyclin B:
5′-GCACTTTCCTCCTTCTCA-3′ (forward) and 5′-TTCGATGTGGCA-
TACTTG-3′ (reverse), cyclin D: 5′-TCCTGTGCTGCGAAGTGGAG-3′
(forward) and 5′-AAATCGTGGGGAGTCATGGC-3′ (reverse), cyclin
E: 5′-TAAGCTCCACAGAGAGACAT-3′ (forward) and 5′- ACACCACT-
GATAACCTGAGA-3′ (reverse), and GAPDH: 5′-GACCTGACCTG-
CCGTCTA-3′ (forward) and 5′-AGGAGTGGGTGTCGCTGT-3′ (re-
verse). All real-time PCRs were performed in triplicate, and
changes in gene expressions were presented as multiples of in-
creases relative to the untreated controls.
2.9. Western blot analysis
Cells were treated with 0, 10, 25 and 50 μM tryptanthrin for
24 h, and then rinsed twice with ice-cold PBS and harvested in a
lysis buffer (20 mM HEPES, 20 mM NaF, 1 mM Na3VO4, 1 mM
Na4P2O7, 1 mM EDTA, 1 mM EGTA, 1 mM DTT, 0.5 mM PMSF,
1 μg/mL leupeptin and 1% Triton X-100) followed by sonication.
The protein concentration of the cell extracts was determined by
the Bradford assay (Bio-Rad Laboratories, Richmond, CA). Samples
with equal amount of proteins were boiled in sodium dodecyl
sulfate (SDS) sample buffer and separated by 10% SDS-poly-
acrylamide gel electrophoresis (PAGE). Gels were blotted over-
night onto polyvinylidenediﬂuoride (PVDF) membranes. Mem-
branes were blocked with 1% BSA and 1% goat serum in PBS for
30 min at room temperature. After washing in PBS, membranes
were incubated with the primary antibodies: anti-CDK1 (mouse,
Thermo Scientiﬁc), anti-CDK2 (mouse, Thermo Scientiﬁc),
anti-cyclin A (mouse, Thermo, Scientiﬁc), anti-cyclin B (mouse,
Thermo Scientiﬁc), anti-cyclin D (mouse, Thermo Scientiﬁc), anti-
Fig. 7. Tryptanthrin inhibited the activation of Akt and FAK pathways. Cells were treated with 0, 10, 25 and 50 μM tryptanthrin for 24 h. (A) Western blot analysis for the
native or phosphorylated forms of Akt and FAK was performed with tubulin used as an internal control. (B, C) Densitometric analysis of the protein levels in (A). Results were
presented as mean7SEM from three independent experiments (compared with control, *Po0.05).
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ing), anti-phospho-Akt (Ser473, rabbit, Cell Signaling), anti-phos-
pho-Akt (Thr308, rabbit, Cell signaling), anti-FAK (rabbit, Thermo
Scientiﬁc), anti-phospho-FAK (rabbit, Santa Cruz), anti-p44/p42
MAPK (rabbit, Cell Signaling), and anti-phospho-p44/p42 MAPK
(rabbit, Cell Signaling) at an appropriate dilution (1:200, 1:200,
1:200, 1:200, 1:200, 1:200, 1:1000, 1:1000, 1:1000, 1:1000, 1:1000,
1:1000, 1:1000, respectively) for 2 h at room temperature, and
further incubated with goat anti-rabbit/mouse immunoglobulin G
(IgG) conjugated with HRP-conjugated secondary antibodies (Cell
Signaling, Danvers, MA, USA) for 1 h. Anti-tubulin antibody
(1:800) was used as the sample loading control. The protein bands
were conﬁrmed using the enhanced chemiluminescence reagent
(Amersham Pharmacia Biotech, Little Chalfont, UK).
2.10. Statistical analysis
Results were represented as mean7SEM. Statistical differences
were determined by independent and paired Student's t-test in
unpaired and paired samples. Values were considered to be sig-
niﬁcant at p less than 0.05. All experiments were repeated at least
three times independently.
3. Results
3.1. Indigo naturalis inhibited VEGF-induced in vivo angiogenesis, as
well as tryptanthrin
To determine whether indigo naturalis and tryptanthrin exert
anti-angiogenic effect, in vivo CAM assay was performed for this
purpose. As shown in Fig. 2, VEGF signiﬁcantly increased the blood
vessel density in chick chorioallantoic membrane that was in-
hibited in the presence of indigo naturalis or tryptanthrin. The
angiogenesis index for the control, VEGF, VEGF with indigo nat-
uralis, and VEGF with tryptanthrin treatment group was
10078.3%, 230.674.8%, 166.7714.4%, and 130.5733.7%, re-
spectively. The results conﬁrmed the in vivo inhibitory effect of
indigo naturalis and tryptanthrin on angiogenesis.3.2. Inhibitory effect of indigo naturalis and tryptanthrin on cell
proliferation and cell cycle progression
In Fig. 3A and B, both indigo naturalis and tryptanthrin, re-
duced the number of viable vascular endothelial cells dose-de-
pendently as analyzed by MTT assay. The percentage change of
OD570 nm in each group compared with control was 100.571.3%,
95.372.7%, 89.372.7%, 77.574.3%, and 6172.2% for cells treated
with 10, 50, 250, 500, and 1000 μg/ml indigo naturalis, respec-
tively. The percentage change of OD570 nm in each group compared
with control was 99.670.3%, 82.970.3%, and 68.271% for cells
treated with 10, 25 and 50 μM tryptanthrin, respectively. Flow
cytometric analysis of vascular endothelial cells treated with
50 μM tryptanthrin demonstrated S phase reduction and G2/M
arrest of the cell cycle (Fig. 3C). In the control group, there were
49.94% cells in G0/G1 phase, 36.14% cells in S phase, and 13.92% in
G2/M phase. However, the percentage of cells in S phase decreased
to 28.48% and G2/M phase increased to 29.25% signiﬁcantly after
24 h of tryptanthrin treatment (Fig. 3D). The result suggested that
the anti-angiogenic effect of tryptanthrin was associated with the
cell cycle control. In addition, the ﬂow cytometric data did not
detect signiﬁcant amount of subG1 cells after the tryptanthrin
treatment that ruled out the possibility of cell apoptosis induced
by tryptanthrin under this experimental condition.
3.3. Effect of tryptanthrin on cell cycle related genes in vascular
endothelial cells
To further examine the regulatory role of tryptanthrin on cell
cycle, we analyzed the mRNA and protein expression of cyclin
family and CDKs in vascular endothelial cells. As shown in Fig. 4A,
tryptanthrin had no effect on the expression of cyclin D and E, but
it exerted dose-dependent inhibitory effect on the mRNA levels of
cyclin A and B. CDK1 and CDK2 mRNA level also reduced at high
concentration of tryptanthrin (Fig. 4B). Results from Western blot
analysis as shown in Fig. 4C revealed a similar effect of tryptan-
thrin on the protein expression levels of these genes, and the
densitometric analysis of the protein levels was shown in Fig. 4D.
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tube formation
To further investigate the anti-angiogenic effect of tryptanthrin,
transwell migration assay and gel-induced tube formation assay
were performed. In migration assay, human vascular endothelial
cells treated with different concentration of tryptanthrin were
allowed to migrate for 4 h, and cells migrated through ﬁlter were
counted (Fig. 5A). A dose-dependent inhibitory effect was proved
(Fig. 5B). The percentages of cells treated with 10, 25 and 50 μM of
tryptanthrin compared to control were 7872.6%, 5872.3%, and
4472.1%, respectively.
In gel-induced tube formation assay, tryptanthrin signiﬁcantly
inhibited tube formation in a dose dependent manner (Fig. 6A).
After 4 h of tube formation, the percentages of cells treated with
10, 25 and 50 μM of tryptanthrin compared to control were
7574.0%, 3274.0%, and 16.771.3%, respectively (Fig. 6B). These
results demonstrated the in vitro anti-angiogenic effect of
tryptanthrin.
3.5. Tryptanthrin inhibited Akt and FAK pathways in vascular en-
dothelial cells
Since tryptanthrin was proved to have effect on cell cycle, cell
migration, and tube formation, the related pathways including Akt
and FAK were studied. After treating with different concentration
of tryptanthrin in vascular endothelial cells for 24 h, the expres-
sions of native and phosphorylated forms of Akt and FAK were
analyzed by Western blotting. As shown in Fig. 7, tryptanthrin
signiﬁcantly inhibited the phosphorylation of both Akt and FAK.
This outcome suggested that tryptanthrin exerts its anti-angio-
genesis effect possibly through regulating Akt and FAK pathway.4. Discussion
The pathophysiology of psoriasis is mostly believed to be as-
sociated to immune dysfunction which results in keratinocytes
proliferation, leukocytes inﬁltration, and angiogenesis. In our
previous study, indigo naturalis has been proved to modulate the
differentiation and proliferation of human keratinocytes (Lin et al.,
2009b), improve barrier function of keratinocytes (Lin et al., 2013),
and inhibit tumor necrosis factor-α-induced vascular cell adhesion
molecule-1 expression in human vascular endothelial cells in vitro
(Chang et al., 2010). From the histological analysis of the skin
samples before and after the treatment with indigo naturalis, the
area of rete ridges and vascular formation was decreased sig-
niﬁcantly after the treatment. However, the mechanism re-
sponsible for the anti-angiogenic effect of indigo naturalis was not
yet clariﬁed. Tryptanthrin is one active component of indigo nat-
uralis, and is known for its antimicrobial, anti-tumor effect, and
anti-inﬂammatory effect in previous studies (Jahng, 2013). Since
psoriasis and cancer share the same pathophysiology of vascular
angiogenesis, we are interested in the potential anti-angiogenic
effect of tryptanthrin.
Anti-angiogenic therapy became promising in treating psoriasis
(Winter et al., 2002). VEGF, a potent pro-angiogenic factor which is
abundant in psoriatic lesion, plays an important role in the pa-
thogenesis of psoriasis (Perry and Arbiser, 2006). A previous study
showed that transgenic VEGF could induce psorasiform phenotype
(Xia et al., 2003). Moreover, single nucleotide polymorphism of
VEGF gene is associated with early onset and severe type of
psoriasis (Young et al., 2004). These results suggested that VEGF is
directly related to the pathogenesis of psoriasis and investigation
of VEGF antagonist for psoriasis treatment is becoming a new
trend (Crawshaw et al., 2012).To our knowledge, this is the ﬁrst study to demonstrate the
anti-angiogenesis effect of indigo naturalis and to point out the
mechanism of how tryptanthrin affects the cell cycle of human
vascular endothelial cells which plays an important role in an-
giogenesis. By examining CAM assay treated with indigo naturalis
and tryptanthrin, we demonstrated that the VEGF-induced an-
giogenesis was signiﬁcantly decreased by indigo naturalis and
tryptanthrin in vivo. Direct effect of indigo naturalis and tryptan-
thrin on reducing the number of viable vascular endothelial cells
was proved by MTT assay in a concentration-dependent manner.
The cell cycle analysis in our ﬁnding indicated a G2/M arrest effect
exerted by tryptanthrin. To further investigate the change of cell
cycle-dependent genes, we examined the mRNA and protein ex-
pressions of cyclins and CDKs. Cyclins are a family of proteins that
control the progression of cells through the cell cycle by forming
complex with CDKs (Galderisi et al., 2003). Cyclin D, E, and CDK2
play a key role in the transition of G1 to S phase in cell cycle (Nigg,
1995; Resnitzky and Reed, 1995), while cyclin B and CDK1 con-
tribute to G2/M transition (Smits and Medema, 2001). Cyclin A,
which is associated with both CDK1 and CDK2, is the only cyclin
that regulates multiple steps of the cell cycle (Pagano et al., 1992).
In our study, tryptanthrin demonstrated a signiﬁcant inhibition of
cyclin B and cyclin A, but no effect on cyclin D and E. Moreover,
CDK1 and CDK2 is also decreased by tryptanthrin at higher con-
centration. These results revealed G2/M arrest in cell cycle to be
the underlining mechanism for the anti-angiogenic effect of
tryptanthrin.
VEGF is known to trigger the process of proliferation, migra-
tion, and tube formation of vascular endothelial cells (Zhou et al.,
2013). The subsequent downstream signals including Akt and FAK
are activated by being phosphorylated upon VEGF stimulation, are
also inhibited by tryptanthrin in the present study. Serine/threo-
nine kinase Akt is a major mediator of cell growth as well as cell
cycle regulation (Zhang et al., 2013), and FAK is also important in
signal transduction such as endothelial cell migration and survival
in the process of angiogenesis (Drougard et al., 2014). The PI3K/Akt
and FAK signaling cascades therefore are responsible for the anti-
mitotic effect of tryptanthrin.
The anti-angiogenic effect of tryptanthrin has recently been
reported with different mechanism (Liao et al., 2013). Liao's study
was carried out in HMEC-1 cells and extracellular signal-regulated
kinase (ERK) signal pathway, particularly ERK1, was the only
pathway found to be affected by tryptanthrin. human micro-
vascular endothelial cells (HMEC-1) cells, an immortalized human
endothelial cell line, highly express SV 40A/large T antigen that are
quite different from primary endothelial cells cultured from hu-
man umbilical cord vein used in our study. Compared to the ab-
normal cycle control of HMEC-1 cells that is interfered by over-
expressed SV 40A and large T antigen, primary vascular en-
dothelial cells are more suitable for the cell cycle study. In our
study, both Akt and FAK signal pathways were shown to be re-
duced by tryptanthrin dose-dependently that were correlated well
with the inhibition of cell proliferation.
Besides proliferation, the migration and tube formation of
vascular endothelial cells are also important steps in the process of
angiogenesis. In our in vitro study, tryptanthrin exerted an in-
hibitory effect on cell migration and tube formation in a dose-
dependent manner. More interestingly, our experiments were
carried out using primary vascular endothelial cells pre-treated
with tryptanthrin for 24 h and both migration and tube formation
assay were performed in the absence of tryptanthrin which was
different from Liao's study, suggesting a sustained inhibitory effect
of tryptanthrin which made it a more potent agent to be devel-
oped into a new anti-angiogenic drug.
In conclusion, indigo naturalis is demonstrated to have anti-
angiogenic effect; and tryptanthrin, the main active component of
H.-N. Chang et al. / Journal of Ethnopharmacology 174 (2015) 474–481 481indigo naturalis, exhibited the anti-angiogenic potency by causing
G2/M phase arrest, suppressing migration and tube formation of
human vascular endothelial cells through inhibiting Akt and FAK
pathway. These results indicate that tryptanthrin has signiﬁcant
effect on anti-angiogenesis in vivo and in vitro, which might con-
tribute to the therapeutic mechanism of indigo naturalis on anti-
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